While it is undoubtedly true that modern medicine is more or less able to treat some of the diseases that were previously thought to be incurable, it is also true that ever more complex chemical compounds used in modern pharmacology often cause unpredictable side-effects, which sometimes lead to the development of secondary diseases.
Traditional (or what is sometimes called “alternative”) pharmacopoeia offers solutions which can be less detrimental. However, taken out of the context of the entire traditional natural healing methodology, these medicinal compounds are often less efficient and could cause harmful side-effects of their own.
One possible alternative to the problems mentioned above is the use of modern and innovative electrotherapeutic medical devices. When appropriately implemented, use of various types of electrical currents, magnetic, electric and electromagnetic fields, allows for direct modification of cellular metabolism of both prokaryotes and eukaryotic cells. Additionally, problems with different rate of absorption into various tissues inherent in both modern and traditional pharmacopoeia based therapies are mainly, although not entirely, overcome by using tissue-penetrating EM fields. Admittedly, it is quite possible to cause cellular damage if one is not observant of some basic rules. However, when implemented correctly, a new approach to medical therapies is indeed possible.
The majority of conventional electrotherapy devices used in modern medicine, often in the area of physical rehabilitation, are a derivation of galvanic current therapy, TENS stimulation or low strength oscillating magnetic field. Such devices are used almost exclusively in the treatment of pain, muscular stimulation and facilitation of bone healing processes. The overall effectiveness of such electrotherapy devices is limited because they are primarily used for the treatment of symptoms. They are not capable of addressing the underlying medical conditions that have initially caused the symptoms to develop.
Furthermore, they are incapable of directly inducing significant bioactive effects such as cellular metabolism modification and rejuvenation, eradication of pathogens, induction of programmed apoptosis of neoplastic cells or direct modification of the body’s pH.
On the other hand, there are many old electrotherapeutic technologies like Rife plasma antenna radiator and Lakhovsky Multiple Wave Oscillator devices that are capable of achieving some of the aforementioned bioactive effects but are also rather specialised in their function.
Work on innovative electrotherapy devices
I started as experimenting with Rife type of technologies back in 2000. It took nearly two and a half years to produce the first device capable of generating an appropriate high-frequency signal, modulating it and mixing it, in a way that allowed to experiment with much more complex waveforms. Experimenting with pulsed magnetic field (PMF) devices also started to determine if any common denominators exist, making them more (or less) efficient for “in vivo” medical treatments. It took another five years before managing to “connect the dots” and until realising there are indeed some common factors responsible for induced bioactive effects observed during experimentation with different technologies.
At that point, started considering what would be the best way to use practically gained knowledge to produce new types of electromedical devices, which would be capable of treating some of the medical conditions and diseases, which are otherwise untreatable by using any other publicly known technology.
Initially, the idea was to design a single device which would embody all of the underlying principles I observed during my previous years of research. However, it soon became evident that it would be practically impossible for me to develop such “super”-electrotherapeutic device with limited funds I had at my disposal during that period. Instead, I chose to focus on the development of separate, more specialised electrotherapy devices, which could address some of the problems inherent in modern pharmacological, medical treatments.
Cell metabolism rejuvenation
At first, I focused on the development of the electromedical device that would be capable of producing specific, complex signals capable of stimulating cell metabolism rejuvenation by modifying electrochemical reactions in and around the living cells. The goal was primarily to stimulate ionic exchange processes of the Na+/K+ ionic pump (-ATPase), which would, in turn, increases cellular energy exchange processes and cellular transmembrane potential.
What I have found was that it is indeed possible to directly increase transmembrane potential by applying specially synthesised electrical signals, thus directly affecting the cellular ionic exchange processes. To achieve that I decided to abandon somewhat complex and expensive technologies based on plasma antenna radiators (for example “Rife” technologies) that required more complex electrical design and relatively expensive parts. Finally, I decided to start the development of the device based on the application of the electrical signal by direct electrodes contact with the body. Although beneficial effects on the body were immediate and undeniable, I spent the most of the development time on designing the electronics circuitry, which would be safe enough to use in the clinical environment while retaining all of the beneficial properties.
In 2008 I made the first entirely functional prototype for experimental purposes. At that point, the device was tested in a small clinic in the Netherlands, primarily for the treatment of pain. Based on the feedback I got, I designed two additionally improved developmental generations of the cell metabolism rejuvenation device and made it even more versatile.
Interestingly enough, it also fast became evident that this type of electromedical device appears to have the most interesting beneficial side-effects. With the proper settings of the output signal and use of appropriate electronic circuitry, it appears that it is possible to induce programmed apoptosis in cells with low transmembrane potential (for example neoplastic cells), while at the same time ionic exchange processes are stimulated in the somewhat healthier cells (electrically speaking). Thus normalisation of their transmembrane potential and metabolic processes has been achieved.
Although the device was designed with the capability of directly increasing transmembrane cell potential, it was still a bit of surprise to find that specific electrical signals can selectively induce cellular “suicide” of neoplastic (low transmembrane potential) cells, while not harming the healthy cells.
The effects of selective killing of various types of prokaryotes with no apparent damage to the eukaryotic cells were no surprise to me but what did surprise me was that pretty much similar effects were observed with certain viral infections. For example, I observed that virus count in the blood of the cat suffering from FIV infection (which is somewhat similar to HIV) dropped rapidly and significantly when the cat was treated with electrical signals produced by the device.
Although this type of electrotherapeutic methods appears somewhat promising in the treatments of several different types of medical conditions and diseases, it must be noted that this device is not a panacea. It certainly has its limitations, and in the case of some diseases, it exhibited minimal effectiveness due to the different underlying mechanisms of their genesis.
Direct modification of body pH and neutralisation of excessive levels of free radicals
Concurrently with the development of the cell metabolism rejuvenation device, I have also been developing an entirely different type of electrotherapy device, which can very quickly and efficiently modify and regulate body pH in a direct way as well as to neutralise free radicals “in vivo”.
Due to my previous involvement with the commercial project of zeolite processing and enhancement for medicinal purposes, I was aware of the significance of using strong antioxidants for modification of body pH (alkalisation in this case) and neutralisation of excessive levels of free radicals. They proved to be the significant contributing factors in the successful treatment of some neoplastic and autoimmune diseases. At that point, I already developed a prototype for industrial processing and electrochemical enhancement of zeolite and similar micronised minerals, which measurably increases their electrochemical reactiveness several times. Although the resulting enhanced mineral products exhibit highest physically possible antioxidative properties, which are several times higher compared with commonly used antioxidants and conventionally micronised and activated zeolite, I was still not content with the achieved rate of neutralisation of excessive free radical levels.
I knew that in most severe cases of neoplastic and autoimmune diseases, fast and efficient alkalisation of the affected tissues and the entire body, as well as reduction of excessive levels of free radicals, are of paramount importance.
Although I found somewhat interesting references to historical, as well as somewhat more modern devices trying to achieve such effects “in vitro” in limited laboratory conditions, my initial experiments indicated that things are somewhat more complex if one is to achieve similar effects “in vivo” with complex multicellular organisms like humans and animals.
Initial experiments “in vitro” proved to me that the concept I had in mind was viable. However, it required further experimentation to determine what would be the most efficient way of achieving the same results “in vivo” reliably and safely. For example, I found that when the amplitude of oscillation of the experimental device output was too low, the rate of free radicals neutralisation was virtually negligible.
On the other hand, when the output amplitude of oscillation was too high, it sometimes leads to unpleasant side-effects of nervous system over-excitation, resulting in mild spatial disorientation and vertigo.
I finally overcome those initial obstacles during late 2008 and early 2009, which lead to the successful development of the first and rather unsophisticated prototype. Even in those early stages of development, the results were, and they could be reliably reproduced and verified by laboratory tests done by any medical biochemistry laboratory. With additional funding provided at that stage of development, the device evolved into two more advanced generations based on the data gathered during testing in the small clinic in the Netherlands.
Once perfected, this device proved to be extremely efficient in very fast, controlled alkalisation of the entire organism and reduction of excessive levels of free radicals. This fast and non-invasive method of neutralisation of free radicals shows excellent potential in the treatment of all medical conditions that are caused and indicated by high levels of free radicals in and around the affected tissues.
Aside from the obvious applications as a supplemental therapy in case of various neoplastic and autoimmune diseases, one of the more exciting fields of use is in anti-ageing treatments and reduction of cellular damage caused by exposure to ionising radiations. Distinct sources of such ionising radiations are various X-ray, CT and PET scans which directly cause the production of excessive levels of free radicals in the organism.
The human and animal population increasingly absorbs radioactive “hot particles” released by nuclear accidents. Each of those embedded radioactive “hot” particles invariably causes continuously increased production of free radicals, which often leads to the development of various degenerative and neoplastic diseases (for example thyroid cancer). Perhaps even more interesting application of this technology is to reduce detrimental long-term effects of accumulated radioactive “hot” particles in the organism.
Current research and development of new types of electrotherapy devices
Currently, I am working on entirely new technologies based on the knowledge and experience gained on my work and experiments with previously described devices. Additionally, I have had an opportunity to design, produce and perform experiments with historical replicas of Lakhovsky Multiple Wave Oscillator and Rife “Beam Ray” plasma antenna radiator devices.
It appears that some aspects in all of those technologies have common denominators, which could be used to design and produce even more effective and capable electrotherapeutic devices. Plasma antenna radiator elements are of particular interest, in this case, considering the possibility of modifying their radiation properties without a necessity to change their components physically. Such new technologies should be capable of inducing additional beneficial bioactive effects, some of which are virtually impossible to achieve even with the last developmental generations of the current electromedical devices.